Show source-provided references
1. Breast Cancer, and World Health Organization (2023, January 01). 2023 [Kaynak 08 Haziran 2023]. Available online: https://www.who.int/news-room/fact-sheets/detail/breast-cancer.
3. Aldawsari, H.M., and Singh, S. (2020). Rapid microwave-assisted cisplatin-loaded solid lipid nanoparticles: Synthesis, characterization and anticancer study. Nanomaterials, 10.
10.3390/nano10030510 ↗5. Ultrasmall targeted nanoparticles with engineered antibody fragments for imaging detection of HER2-overexpressing breast cancer
10.1038/s41467-018-06271-5 ↗6. Near-infrared fluorescence imaging for noninvasive trafficking of scaffold degradation
10.1038/srep01198 ↗8. Aptamer-conjugated nanomaterials for specific cancer cell recognition and targeted cancer therapy
10.1038/am.2014.12 ↗9. Sitia, L., Sevieri, M., Signati, L., Bonizzi, A., Chesi, A., and Mainini, F. (2022). HER-2-targeted nanoparticles for breast cancer diagnosis and treatment. Cancers, 14.
10.3390/cancers14102424 ↗11. Nanoradiopharmaceuticals for breast cancer imaging: Development, characterization, and imaging in inducted animals
10.2147/OTT.S110787 ↗12. 99mTc- Anionic dendrimer targeted vascular endothelial growth factor as a novel nano-radiotracer for in-vivo breast cancer imaging
10.1016/j.bioorg.2022.106085 ↗13. Amelioration of tumor targeting and in vivo biodistribution of 99mTc-methotrexate-gold nanoparticles (99mTc-Mex-AuNPs)
10.1016/j.xphs.2021.03.021 ↗16. Yamaguchi, H., Tsuchimochi, M., Hayama, K., Kawase, T., and Tsubokawa, N. (2016). Dual-labeled near-infrared/99mTc imaging probes using PAMAM-coated silica nanoparticles for the imaging of HER2-expressing cancer cells. Int. J. Mol. Sci., 17.
10.3390/ijms17071086 ↗17. 99mTc-radiolabeled silica nanocarriers for targeted detection and treatment of HER2-positive breast cancer
10.2147/IJN.S276033 ↗19. Anti-MUC1 nano-aptamers for triple-negative breast cancer imaging by single-photon emission computed tomography in inducted animals: Initial considerations
20. Use of biotin targeted methotrexate-human serum albumin conjugated nanoparticles to enhance methotrexate antitumor efficacy
22. Trastuzumab decorated methotrexate-human serum albumin conjugated nanoparticles for targeted delivery to HER2 positive tumor cells
10.1016/j.ejps.2012.06.016 ↗24. Specific targeting of HER2 overexpressing breast cancer cells with doxorubicin-loaded trastuzumab-modified human serum albumin nanoparticles
10.1021/bc8002452 ↗25. Methotrexate loaded chitosan nanoparticles: Preparation, radiolabeling and in vitro evaluation for breast cancer diagnosis
10.1016/j.jddst.2015.10.004 ↗26. Koźmiński, P., Halik, P.K., Chesori, R., and Gniazdowska, E. (2020). Overview of dual-acting drug methotrexate in different neurological diseases, autoimmune pathologies and cancers. Int. J. Mol. Sci., 21.
10.3390/ijms21103483 ↗27. Enhanced anti-tumoral activity of methotrexate-human serum albumin conjugated nanoparticles by targeting with luteinizing hormone-releasing hormone (LHRH) peptide
10.3390/ijms12074591 ↗28. Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: Preparation and in vitro analysis
30. Lomis, N., Westfall, S., Farahdel, L., Malhotra, M., Shum-Tim, D., and Prakash, S. (2016). Human serum albumin nanoparticles for use in cancer drug delivery: Process optimization and in vitro characterization. Nanomaterials, 6.
10.3390/nano6060116 ↗31. Human serum albumin nanoparticles as a versatile vehicle for targeted delivery of antibiotics to combat bacterial infections
10.1016/j.nano.2023.102685 ↗35. Development and preclinical evaluation of a near-infrared fluorescence probe based on tailored hepatitis B Core particles for imaging-guided surgery in breast cancer
10.2147/IJN.S343479 ↗36. Cancer nanotargeted radiopharmaceuticals for tumor imaging and therapy
38. Optimization the Preparation Process of Methotrexate Loaded Human Serum Albumin Nanoparticles. Içinde: 12th International Symposium on Pharmaceutical Sciences
40. Human serum albumin (HSA) nanoparticles stabilized with intermolecular disulfide bonds
10.1039/c3cc38397k ↗42. RP-HPLC method for estimation of ado-trastuzumabe emtansine injection in pharmaceutical dosage form
43. Romidepsin induces cell cycle arrest, apoptosis, histone hyperacetylation and reduces matrix metalloproteinases 2 and 9 expression in bortezomib sensitized non-small cell lung cancer cells
10.1016/j.biopha.2014.01.002 ↗45. Characterization, optimization, and in vitro evaluation of Technetium-99m-labeled niosomes
10.2147/IJN.S184912 ↗46. Development and in vitro evaluation of positive-charged solid lipid nanoparticles as nucleic acid delivery system in glioblastoma treatment
10.12991/mpj.2018.67 ↗47. Principles of nanoparticle design for overcoming biological barriers to drug delivery
10.1038/nbt.3330 ↗48. Paclitaxel-loaded folate-coated long circulating and pH-sensitive liposomes as a potential drug delivery system: A biodistribution study
10.1016/j.biopha.2017.10.135 ↗49. Danaei, M., Dehghankhold, M., Ataei, S., Hasanzadeh Davarani, F., Javanmard, R., and Dokhani, A. (2018). Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics, 10.
10.3390/pharmaceutics10020057 ↗50. Effect of chemical composition and sonication procedure on properties of food-grade soy lecithin liposomes with added glycerol
10.1016/j.foodres.2017.07.052 ↗51. Skin penetration and deposition of carboxyfluorescein and temoporfin from different lipid vesicular systems: In vitro study with finite and infinite dosage application
10.1016/j.ijpharm.2011.02.006 ↗52. Formulation, characterization and optimization of liposomes containing eicosapentaenoic and docosahexaenoic acids; A methodology approach
54. Synthesis, pharmacoscintigraphic evaluation and antitumor efficacy of methotrexate-loaded, folate-conjugated, stealth albumin nanoparticles
10.2217/nnm.11.53 ↗55. Saeidi, M., Chenani, H., Orouji, M., Adel Rastkhiz, M., Bolghanabadi, S., Vakili, N., Mohamadnia, Z., Hatamie, A., and Simchi, A. (2023). Electrochemical Wearable Biosensors and Bioelectronic Devices Based on Hydrogels: Mechanical Properties and Electrochemical Behavior. Biosensors, 13.
10.20944/preprints202306.0187.v1 ↗58. Ahmad, F., Salem-Bekhit, M.M., Khan, F., Alshehri, S., Khan, A., Ghoneim, M.M., Wu, H.F., Taha, E.I., and Elbagory, I. (2022). Unique properties of surface-functionalized nanoparticles for bio-application: Functionalization mechanisms and importance in application. Nanomaterials, 12.
10.3390/nano12081333 ↗60. Krause, W. (2005). 6-Hydrazinonicotinamide Derivatives as Bifunctional Coupling Agents for 99mTc-Labeling of Small Biomolecules, Springer. Contrast Agents III Topics in Current Chemistry.
10.1007/b94549 ↗61. Preparation, characterization, and biodistribution study of technetium-99m-labeled leuprolide acetate-loaded liposomes in ehrlich ascites tumor-bearing mice
10.1208/ps060105 ↗62. Radiolabeling, pharmacoscintigraphic evaluation and antiretroviral efficacy of stavudine loaded 99mTc labeled galactosylated liposomes
10.1016/j.ejps.2007.12.006 ↗64. Synthesis, 99mTc-labeling, and preliminary biological evaluation of DTPA-melphalan conjugates
10.1002/jlcr.3575 ↗65. Practical considerations for navigating the regulatory landscape of non-clinical studies for clinical translation of radiopharmaceuticals
10.1186/s41181-022-00168-x ↗66. Nanoparticulate formulations of radiopharmaceuticals: Strategy to improve targeting and biodistribution properties
10.1002/jlcr.3839 ↗68. Immune activity and biodistribution of polypeptide K237 and folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles radiolabeled with 99mTc
10.18632/oncotarget.12850 ↗70. The story of MCF-7 breast cancer cell line: 40 years of experience in research
72. Intraductal adaptation of the 4T1 mouse model of breast cancer reveals effects of the epithelial microenvironment on tumor progression and metastasis
10.21873/anticanres.13344 ↗74. Qu, Y., Han, B., Yu, Y., Yao, W., Bose, S., Karlan, B.Y., Giuliano, A.E., and Cui, X. (2015). Evaluation of MCF10A as a reliable model for normal human mammary epithelial cells. PLoS ONE, 10.
10.1371/journal.pone.0131285 ↗